Streetbeat News

Stock Prices

ESPR

Esperion Therapeutics' stock has broken out of a year-long trading range, with potential for a sustainable breakout if support at $3.40 holds. Recent technical achievements and strategic moves, including global drug submissions, improve the stock's outlook. The Piper Sandler Conference highlighted positive guidance and business performance.

Portfolio Pulse from

December 08, 2024 | 1:00 pm

ASML

A class action lawsuit has been filed against ASML Holding N.V. and some of its senior executives for potential violations of federal securities laws. The deadline for affected investors to join the lawsuit is January 13.

Portfolio Pulse from

December 08, 2024 | 12:30 pm

WBD

Warner Bros. Discovery, Inc. is facing a lawsuit for alleged securities law violations. Investors who suffered losses are encouraged to contact Levi & Korsinsky by January 24, 2025, to discuss potential recovery options.

Portfolio Pulse from

December 08, 2024 | 12:30 pm

SYM

A class action lawsuit has been filed against Symbotic Inc. (NASDAQ: SYM) and some of its senior executives for potential violations of federal securities laws. Investors with losses are encouraged to contact Bleichmar Fonti & Auld LLP before the February 3 deadline.

Portfolio Pulse from

December 08, 2024 | 12:30 pm

SVM

Silvercorp's stock has declined by 35-40% due to market overreaction, making it a potential value investment. The Adventus acquisition diversifies its assets and the $150 million senior notes offering provides cheap capital for strategic projects.

Portfolio Pulse from

December 08, 2024 | 12:30 pm

PLTR

Palantir's stock has seen a remarkable increase of 340% in 2024, making it one of the best-performing stocks of the year.

Portfolio Pulse from

December 08, 2024 | 12:30 pm

ZETA

A class action lawsuit has been filed against Zeta Global Holdings Corp. (NYSE: ZETA) and some of its senior executives for potential violations of federal securities laws. Investors with losses are encouraged to contact Bleichmar Fonti & Auld LLP before the deadline on January 21.

Portfolio Pulse from

December 08, 2024 | 12:30 pm

BTI

British American Tobacco (BTI) has seen a 25% year-to-date price gain in 2024, with most of the rally occurring between April and September. This rapid advance is notable for a company typically viewed as an income investment.

Portfolio Pulse from

December 08, 2024 | 12:30 pm

NOW

ServiceNow's GenAI solution, Now Assist, has gained significant traction with 44 clients in Q3 2024, each contributing over $1M. The company shows strong financial growth with a 27% revenue CAGR from 2019-2023, margin expansion, and robust free cash flow. Key growth drivers include international expansion, customer growth, and a large addressable market for AI products.

Portfolio Pulse from

December 08, 2024 | 12:30 pm

TD

A class action lawsuit has been filed against The Toronto-Dominion Bank (NYSE: TD) and some of its senior executives for potential violations of federal securities laws. Investors with losses are encouraged to contact Bleichmar Fonti & Auld LLP before the December 23 deadline.

Portfolio Pulse from

December 08, 2024 | 12:30 pm